Medtronic plc announced it will release its financial results for the second quarter of fiscal year 2026 on Tuesday, November 18, 2025. The quarter ended on October 24, 2025.
The company stated that a news release with summary financial information will be available at approximately 5:45 a.m. Central Standard Time (CST) on its news website at https://news.medtronic.com. A video webcast to discuss the results is scheduled to begin at 7:00 a.m. CST and can be accessed at https://investorrelations.medtronic.com. Medtronic also noted that within 24 hours after the webcast, both a replay and transcript of the prepared remarks will be posted under the Events section at https://investorrelations.medtronic.com.
Looking ahead, Medtronic plans to announce its third quarter results on February 17, 2026, and fourth quarter results on May 20, 2026. The company indicated that confirmation and more details will be shared closer to those dates.
“Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary,” according to information provided by Medtronic.
The company cautioned that any forward-looking statements are subject to risks and uncertainties as described in its filings with the Securities and Exchange Commission.
For further information about Medtronic or investor relations updates visit www.Medtronic.com or follow their LinkedIn page.
